Conceptualization vs reality in the treatment of periodontal diseases.
This article addresses controversial issues associated with four different subjects: the usefulness of povidone iodine in the treatment of adult periodontitis, genetic susceptibility testing for severe periodontitis, local drug delivery in the treatment of periodontal diseases, and differentiating between statistical and clinical significance. Conclusions are drawn based on published evidence. Each subject is also assessed with regard to their practical application in the management of patients.
Greenstein
G
G
Department of Periodontics, University of Medicine and Dentistry of New Jersey, Newark, USA.
D000328:Adult; D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D016503:Drug Delivery Systems; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D006801:Humans; D007375:Interleukin-1 / Q000032:analysis / Q000235:genetics; D016017:Odds Ratio; D010518:Periodontitis / Q000188:drug therapy* / Q000235:genetics*; D011206:Povidone-Iodine / Q000008:administration & dosage*; D013752:Tetracycline / Q000008:administration & dosage
D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D007375:Interleukin-1; D011206:Povidone-Iodine; D013752:Tetracycline